Target intelligence / Profile preview

Leukemia NUP98 fusion partner 1 (LNP1)

Target
LNP1
Molecular classification
Other
01

Overview

Leukemia NUP98 fusion partner 1 (LNP1) is a human protein-coding gene identified primarily as a rare fusion partner of NUP98 in chromosomal rearrangements found in certain aggressive leukemias[2][3][4]. The resulting NUP98::LNP1 fusion protein has only been reported in isolated leukemia cases (notably, one ETP-ALL patient and an AML patient)[2]. LNP1 itself does not possess well-characterized molecular or cellular functions outside its role as a fusion partner. There are no established drugs or therapies targeting the LNP1 protein or the NUP98::LNP1 fusion; however, its presence can be used molecularly to identify the specific disease subtype for diagnostic or residual disease monitoring purposes[2][3].

Other names
LNP1Leukemia NUP98 fusion partner 1Gm19797 (in mouse)NP3
02

Mechanism of action

None specific; not established for LNP1 or NUP98::LNP1 fusion protein Any treatment would target the leukemia broadly, not the fusion protein specifically

03

Biological functions

Other
04

Disease associations

Canceracute leukemiaearly T-cell precursor acute lymphoblastic leukemiaETP-ALLAML
05

Safety considerations

None specifically documented for LNP1 Potential safety issues relate to general anti-leukemic therapies, not the fusion partner itself.
06

Interacting drugs

None specific to LNP1
07

Biomarkers

Detection of NUP98::LNP1 fusion transcript (by molecular methods in leukemia diagnosis)

Beyond the preview

Go deeper on Leukemia NUP98 fusion partner 1 (LNP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leukemia NUP98 fusion partner 1 (LNP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call